841
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

Increasing awareness and uptake of the MenB vaccine on a large university campus

, , , , , , & show all
Pages 3239-3246 | Received 12 Jan 2021, Accepted 23 Apr 2021, Published online: 02 Jun 2021

References

  • Mbaeyi SA, Joseph SJ, Blain A, Wang X, Hariri S, MacNeil JR. Meningococcal disease among college-aged young adults: 2014–2016. Pediatrics. 2019;143(1):e20182130. doi:10.1542/peds.2018-2130.
  • MacNeil JR, Blain AE, Wang X, Cohn AC. Current epidemiology and trends in meningococcal disease—United States, 1996–2015. Clin Infect Dis. 2017;66(8):1276–81. doi:10.1093/cid/cix993.
  • Wang B, Santoreneos R, Giles L, Haji Ali Afzali H, Marshall H. Case fatality rates of invasive meningococcal disease by serogroup and age: a systematic review and meta-analysis. Vaccine. 2019;37(21):2768–82. doi:10.1016/j.vaccine.2019.04.020.
  • Capitano B, Dillon K, LeDuc A, Atkinson B, Burman C. Experience implementing a university-based mass immunization program in response to a meningococcal B outbreak. Hum Vaccin Immunother. 2019;15(3):717–24. doi:10.1080/21645515.2018.1547606.
  • Patton ME, Stephens D, Moore K, MacNeil JR. Updated recommendations for use of MenB-FHbp serogroup B meningococcal vaccine - advisory committee on immunization practices, 2016. MMWR Morb Mortal Wkly Rep. 2017;66(19):509–13. doi:10.15585/mmwr.mm6619a6.
  • Packnett E, Irwin DE, Novy P, Watson PS, Whelan J, Moore-Schiltz L, Lucci M, Hogea C. Meningococcal-group B (MenB) vaccine series completion and adherence to dosing schedule in the United States: a retrospective analysis by vaccine and payer type. Vaccine. 2019;37(39):5899–908. doi:10.1016/j.vaccine.2019.06.065.
  • Walker TY, Elam-Evans LD, Yankey D, Markowitz LE, Williams CL, Fredua B, Singleton JA, Stokley S. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2018. MMWR Morb Mortal Wkly Rep. 2019;68(33):718–23. doi:10.15585/mmwr.mm6833a2.
  • Mehta P, Sharma M, Lee RC. Designing and evaluating a health belief model-based intervention to increase intent of HPV vaccination among college males. Int Q Community Health Educ. 2014;34(1):101–17. doi:10.2190/IQ.34.1.h.
  • Soeters HM, Whaley M, Alexander-Scott N, Kanadanian KV, MacNeil JR, Martin SW, McNamara LA, Sicard K, Vanner C, Vuong J, et al. Meningococcal carriage evaluation in response to a serogroup B meningococcal disease outbreak and mass vaccination campaign at a college—Rhode Island, 2015–2016. Clin Infect Dis. 2017;64(8):1115–22. doi:10.1093/cid/cix091.
  • Oliver SE, Patton ME, Hoban M, Leino V, Mbaeyi SA, Hariri S, MacNeil JR. Evaluation of meningococcal vaccination policies among colleges and universities — United States, 2017. J Am Coll Health. 2019:1–6. doi:10.1080/07448481.2019.1687484.
  • Nan X, Kim J. Predicting H1N1 vaccine uptake and H1N1-related health beliefs: the role of individual difference in consideration of future consequences. J Health Commun. 2014;19(3):376–88. doi:10.1080/10810730.2013.821552.
  • Barnard M, Cole AC, Ward L, Gravlee E, Cole ML, Compretta C. Interventions to increase uptake of the human papillomavirus vaccine in unvaccinated college students: a systematic literature review. Prev Med Rep. 2019;14:100884. doi:10.1016/j.pmedr.2019.100884.
  • Shropshire AM, Brent-Hotchkiss R, Andrews UK. Mass media campaign impacts influenza vaccine obtainment of university students. J Am Coll Health. 2013;61(8):435–43. doi:10.1080/07448481.2013.830619.
  • Huang JJ, Francesconi M, Cooper MH, Covello A, Guo M, Gharib SD. Community health workers on a college campus: effects on influenza vaccination. J Am Coll Health. 2018;66(4):317–23. doi:10.1080/07448481.2018.1440582.
  • Niccolai LM, Yakely AE, Hansen CE. Up-to-date coverage with meningococcal vaccine among adolescents age 17 years: patterns and correlates in the United States, 2017. Vaccine. 2019;37(40):5934–38. doi:10.1016/j.vaccine.2019.08.015.
  • Soeters HM, McNamara LA, Whaley M, Wang X, Alexander-Scott N, Kanadanian KV, Kelleher CM, MacNeil J, Martin SW, Raines N, et al. serogroup B meningococcal disease outbreak and carriage evaluation at a college - Rhode Island, 2015. MMWR Morb Mortal Wkly Rep. 2015;64(22):606–07.
  • Breakwell L, Whaley M, Khan UI, Bandy U, Alexander-Scott N, Dupont L, Vanner C, Chang H-Y, Vuong JT, Martin S, et al. Meningococcal carriage among a university student population – United States, 2015. Vaccine. 2018;36(1):29–35. doi:10.1016/j.vaccine.2017.11.040.
  • McNamara LA, Thomas JD, MacNeil J, Chang HY, Day M, Fisher E, Martin S, Poissant T, Schmink SE, Steward-Clark E, et al. Meningococcal carriage following a vaccination campaign with MenB-4C and MenB-FHbp in response to a university serogroup B meningococcal disease outbreak-Oregon, 2015-2016. J Infect Dis. 2017;216(9):1130–40. doi:10.1093/infdis/jix446.
  • Soeters HM, McNamara LA, Blain AE, Whaley M, MacNeil JR, Hariri S, Mbaeyi SA. Serogroup B meningococcal disease university outbreak group. University-based outbreaks of meningococcal disease caused by serogroup B, United States, 2013–2018. Emerg Infect Dis. 2019;25(3):434–40. doi:10.3201/eid2503.181574.
  • Alderfer J, Isturiz RE, Srivastava A. Lessons from mass vaccination response to meningococcal B outbreaks at US universities. Postgrad Med. 2020:1–10. doi:10.1080/00325481.2020.1766265.
  • Breakwell L, Vogt TM, Fleming D, Ferris M, Briere E, Cohn A, Liang JL. Understanding factors affecting university: students’ decision to receive an unlicensed serogroup B meningococcal vaccine. J Adolesc Health. 2016;59(4):457–64. doi:10.1016/j.jadohealth.2016.06.004.
  • MacDougall DM, Langley JM, Li L, Ye L, MacKinnon-Cameron D, Top KA, McNeil SA, Halperin BA, Swain A, Bettinger JA, et al. Knowledge, attitudes, beliefs, and behaviors of university students, faculty, and staff during a meningococcal serogroup B outbreak vaccination program. Vaccine. 2017;35(18):2520–30. doi:10.1016/j.vaccine.2017.02.011.
  • Institutional Planning and Research. UF facts: enrollment. Gainesville: University of Florida; 2021 Feb 22 [accessed 2021 Mar 31]. https://ir.aa.ufl.edu/uffacts/enrollment-1/.
  • Food and Drug Administration. Bexsero U.S. package insert. US Department of Health and Human Services, Food and Drug Administration.Silver Spring (MD); 2015. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM431447.pdf
  • Food and Drug Administration. Trumenba U.S. package insert. Department of Health and Human Services, Food and Drug Administration, Silver Spring (MD); 2014. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM421139.pdf
  • National Cancer Institute. Health information national trends survey. National Institutes of Health; 2014 [accessed 2021 Mar 31]. https://hints.cancer.gov/data/survey-instruments.aspx.
  • The Child & Adolescent Health Measurement Initiative. National survey of children’s health questionnaire. 2018. [accessed 2021 Mar 31]. https://www.childhealthdata.org/learn-about-the-nsch/survey-instruments.
  • Glanz K, Rimer BK, Viswanath K. Health behavior and health education: theory, research, and practice. San Francisco (CA): Wiley; 2008.
  • Kurosky SK, Esterberg E, Irwin DE, Trantham L, Packnett E, Novy P, Whelan J, Hogea C. Meningococcal vaccination among adolescents in the United States: a tale of two age platforms. J Adolesc Health. 2019;65(1):107–15. doi:10.1016/j.jadohealth.2019.02.014.
  • Mcnamara L, Thomas J, Macneil J, Day M, Fisher E, Martin SW, Poissant T, Wang X, Acosta AM. Meningococcal carriage evaluation in response to a serogroup B meningococcal disease outbreak and mass vaccination campaign at a university—Oregon, 2015. Open Forum Infect Dis. 2016;3(suppl_1). doi:10.1093/ofid/ofw172.585.
  • Ritscher AM, Ranum N, Malak JD, Ahrabi-Fard S, Baird J, Berti AD, Curtis W, Holden M, Jones CD, Kind J, et al. Meningococcal serogroup B outbreak response University of Wisconsin-Madison. J Am Coll Health. 2019;67(3):191–96. doi:10.1080/07448481.2018.1469502.
  • Fisher EA, Poissant T, Luedtke P, Leman R, Young C, Cieslak P. Evaluation of mass vaccination clinics in response to a serogroup B meningococcal disease outbreak at a large, public university-Oregon, 2015. J Adolesc Health. 2018;63(2):151–56. doi:10.1016/j.jadohealth.2018.03.018.
  • Bednarczyk RA, King AR, Lahijani A, Omer SB. Current landscape of nonmedical vaccination exemptions in the United States: impact of policy changes. Expert Review of Vaccines. 2019;18(2):175–90. doi:10.1080/14760584.2019.1562344.
  • Caleb S, Thompson D, Haimowitz R, Ciotoli C, Dannenbaum M, Fu LY. How colleges intervene to increase student body vaccination coverage. J Am Coll Health. 2020:1–8. doi:10.1080/07448481.2020.1752698.
  • Ramsey MA, Marczinski CA. College students’ perceptions of H1N1 flu risk and attitudes toward vaccination. Vaccine. 2011;29(44):7599–601. doi:10.1016/j.vaccine.2011.07.130.
  • Maurer J. Inspecting the mechanism: a longitudinal analysis of socioeconomic status differences in perceived influenza risks, vaccination intentions, and vaccination behaviors during the 2009–2010 influenza pandemic. Med Decis Making. 2016;36(7):887–99. doi:10.1177/0272989x15608379.
  • Ryan KA, Filipp SL, Gurka MJ, Zirulnik A, Thompson LA. Understanding influenza vaccine perspectives and hesitancy in university students to promote increased vaccine uptake. Heliyon. 2019;5(10):e02604. doi:10.1016/j.heliyon.2019.e02604.
  • Bednarczyk RA, Chu SL, Sickler H, Shaw J, Nadeau JA, McNutt L-A. Low uptake of influenza vaccine among university students: evaluating predictors beyond cost and safety concerns. Vaccine. 2015;33(14):1659–63. doi:10.1016/j.vaccine.2015.02.033.
  • McDonald B, Haardoerfer R, Windle M, Goodman M, Berg C. Implications of attrition in a longitudinal web-bBased survey: an examination of college students participating in a tobacco use study. JMIR Public Health Surveill. 2017;3(4):e73. doi:10.2196/publichealth.7424.
  • Schaffer DeRoo S, Pudalov NJ, Fu LY. Planning for a COVID-19 vaccination program. JAMA. 2020;323(24):2458–59. doi:10.1001/jama.2020.8711.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.